Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Global ICIs Market Exceeds USD 30 Billion in 2021, with its Number and Indications Approved Entering an Outbreak Period

YiApril 11, 2022

Tag: ICIs , LAG-3 inhibitor , relatlimab , PD-1

PharmaSources Customer Service